Search

everythinglearnresearchcommunity

for

Search:↓

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document is a detailed medical reference on skin and genetic disorders.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Hair loss in women aged 20-30 is often linked to deficiencies in Vitamin D, zinc, ferritin, and haemoglobin, as well as low SHBG levels in those with irregular periods.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 may cause hair loss due to infection stress or treatments.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

AGA linked to worse COVID-19 outcomes in men.

Testosterone may influence COVID-19 severity and outcomes.

Men with severe balding have a higher risk of getting very sick from COVID-19.

Women with high androgen levels may have more severe COVID-19 symptoms.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 infection can significantly cause temporary hair loss.